TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients

Clinical trial NCT06455917 · RECRUITING

Trial details

NCT number: NCT06455917
Sponsor: University Hospital, Basel, Switzerland
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Lung Cancer (NSCLC)

Start date: 2025-01-22
Primary completion: 2029-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.